LongCovid
An excelent systematic review of trials currently investigating treatment for Post-Acute COVID Syndrome (PACS)/longCOVID has been published by the Clinical Microbiology and Infection (CMI).
The review identified 388 registered trials exploring 144 unique interventions for PACS. Most target general alleviation of symptoms. As highlighted by this review, there is an urgent need for further high-quality and methodologically robust PACS treatment trials.
New blog post from Suzan Jackson, a Writer & Person with ME/CFS. There is SO much exciting research happening that will benefit both those of us who’ve had…
📅 22/07/2024 – It’s World Brain Day 2024! Today, let’s raise awareness about brain health and the impact of Long COVID. Many people living with Long COVID experience…
Researchers from the EU H2020 Orchestra project have discovered that treatment with various monoclonal antibodies (mAbs) comes with a serious trade-off: SARSCoV2 mutates in response to the immune-pressure created under…
A new ORCHESTRA study has recently been published in the Virology Journal. Authors measured immune responses in those infected, vaccinated, or experiencing breakthrough cases in two cohorts: a…